Van De Vijver DA - Search Results

1

Risk factors for the development of cataract requiring surgery in uveitis associated with juvenile idiopathic arthritis.

Sijssens KM, Rothova A, Van De Vijver DA, Stilma JS, De Boer JH. Sijssens KM, et al. Among authors: de boer jh, van de vijver da. Am J Ophthalmol. 2007 Oct;144(4):574-9. doi: 10.1016/j.ajo.2007.06.030. Epub 2007 Aug 16. Am J Ophthalmol. 2007. PMID: 17706583

2

Influence of benzodiazepines on antiparkinsonian drug treatment in levodopa users.

van de Vijver DA, Roos RA, Jansen PA, Porsius AJ, de Boer A. van de Vijver DA, et al. Among authors: de boer a. Acta Neurol Scand. 2002 Jan;105(1):8-12. doi: 10.1034/j.1600-0404.2002.00132.x. Acta Neurol Scand. 2002. PMID: 11903102

3

Bacteremic complications of intravascular catheters colonized with Staphylococcus aureus.

Ekkelenkamp MB, van der Bruggen T, van de Vijver DA, Wolfs TF, Bonten MJ. Ekkelenkamp MB, et al. Among authors: van der bruggen t, van de vijver da. Clin Infect Dis. 2008 Jan 1;46(1):114-8. doi: 10.1086/524077. Clin Infect Dis. 2008. PMID: 18171225

4

Start of a selective serotonin reuptake inhibitor (SSRI) and increase of antiparkinsonian drug treatment in patients on levodopa.

van de Vijver DA, Roos RA, Jansen PA, Porsius AJ, de Boer A. van de Vijver DA, et al. Among authors: de boer a. Br J Clin Pharmacol. 2002 Aug;54(2):168-70. doi: 10.1046/j.1365-2125.2001.01491.x. Br J Clin Pharmacol. 2002. PMID: 12207636 Free PMC article. Clinical Trial.

5

Antipsychotics and Parkinson's disease: association with disease and drug choice during the first 5 years of antiparkinsonian drug treatment.

van de Vijver DA, Roos RA, Jansen PA, Porsius AJ, de Boer A. van de Vijver DA, et al. Among authors: de boer a. Eur J Clin Pharmacol. 2002 May;58(2):157-61. doi: 10.1007/s00228-002-0441-x. Epub 2002 Apr 5. Eur J Clin Pharmacol. 2002. PMID: 12012150

6

Evaluation of antiparkinsonian drugs in pharmacy records as a marker for Parkinson's disease.

van de Vijver DA, Stricker BH, Breteler MM, Roos RA, Porsius AJ, de Boer A. van de Vijver DA, et al. Among authors: de boer a. Pharm World Sci. 2001 Aug;23(4):148-52. doi: 10.1023/a:1011807919632. Pharm World Sci. 2001. PMID: 11599201

7

Estimation of incidence and prevalence of Parkinson's disease in the elderly using pharmacy records.

van de Vijver DA, Roos RA, Jansen PA, Porsius AJ, de Boer A. van de Vijver DA, et al. Among authors: de boer a. Pharmacoepidemiol Drug Saf. 2001 Oct-Nov;10(6):549-54. doi: 10.1002/pds.624. Pharmacoepidemiol Drug Saf. 2001. PMID: 11828838

8

Decrease of antiparkinsonian drugs before start of an antipsychotic in patients on levodopa treatment?

van de Vijver DA, Roos RA, Jansen PA, Porsius AJ, de Boer A. van de Vijver DA, et al. Among authors: de boer a. Pharm World Sci. 2004 Oct;26(5):277-81. doi: 10.1023/b:phar.0000042883.58714.a7. Pharm World Sci. 2004. PMID: 15598069

9

Reduction in acquisition of vancomycin-resistant enterococcus after enforcement of routine environmental cleaning measures.

Hayden MK, Bonten MJ, Blom DW, Lyle EA, van de Vijver DA, Weinstein RA. Hayden MK, et al. Among authors: van de vijver da. Clin Infect Dis. 2006 Jun 1;42(11):1552-60. doi: 10.1086/503845. Epub 2006 Apr 27. Clin Infect Dis. 2006. PMID: 16652312

10

Effects of reducing beta-lactam antibiotic pressure on intestinal colonization of antibiotic-resistant gram-negative bacteria.

Nijssen S, Fluit A, van de Vijver D, Top J, Willems R, Bonten MJ. Nijssen S, et al. Intensive Care Med. 2010 Mar;36(3):512-9. doi: 10.1007/s00134-009-1714-y. Intensive Care Med. 2010. PMID: 19921150 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

126 results

Search Page

Filters